<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for GlaxoSmithKline plc (ADR) - Google Finance</title>
<description>News for GlaxoSmithKline plc (ADR) - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:GSK&amp;amp;client=news-rss&amp;amp;ei=ORedUeGsOrGr0AHq1AE</link>
<image>
<title>News for GlaxoSmithKline plc (ADR) - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:GSK&amp;amp;client=news-rss&amp;amp;ei=ORedUeGsOrGr0AHq1AE</link>
</image>
<item>
<title>AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck &amp;amp; Co ...</title>
<link>http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-glaxosmithkline-plc-adr-gsk-merck-co-inc-mrk-eli-lilly-co-lly-abbvie-inc-abbv-the-5-highest-paying-dividend-stocks-in-big-pharma-147503/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982069647168</guid>
<pubDate>Wed, 22 May 2013 16:56:25 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-glaxosmithkline-plc-adr-gsk-merck-co-inc-mrk-eli-lilly-co-lly-abbvie-inc-abbv-the-5-highest-paying-dividend-stocks-in-big-pharma-147503/&quot; style=&quot;font-size:1.2em&quot;&gt;AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck &amp;amp; Co ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;2 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc ...</title>
<link>http://www.insidermonkey.com/blog/glaxosmithkline-plc-adr-gsk-sanofi-sa-adr-sny-theravance-inc-thrx-this-week-in-biotech-144720/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/glaxosmithkline-plc-adr-gsk-sanofi-sa-adr-sny-theravance-inc-thrx-this-week-in-biotech-144720/</guid>
<pubDate>Mon, 20 May 2013 13:42:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/glaxosmithkline-plc-adr-gsk-sanofi-sa-adr-sny-theravance-inc-thrx-this-week-in-biotech-144720/&quot; style=&quot;font-size:1.2em&quot;&gt;GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 20, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (ADR) Starting in reverse, Elan Corporation, plc (ADR) (NYSE:ELN) surprised investors on Monday by coming out of the bleachers and entering into a $1 billion royalty deal with Theravance Inc (NASDAQ:THRX).&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Biopharma News: Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc ...</title>
<link>http://www.insidermonkey.com/blog/biopharma-news-amarin-corporation-plc-adr-amrn-glaxosmithkline-plc-adr-gsk-abbott-laboratories-abt-125171/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778129202461</guid>
<pubDate>Tue, 23 Apr 2013 16:19:24 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/biopharma-news-amarin-corporation-plc-adr-amrn-glaxosmithkline-plc-adr-gsk-abbott-laboratories-abt-125171/&quot; style=&quot;font-size:1.2em&quot;&gt;Biopharma News: Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Editor&amp;#39;s Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Obagi Medical Products, Inc. (NASDAQ:OMPI) ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AstraZeneca plc (ADR) (AZN): The Latest News</title>
<link>http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-the-latest-news-142013/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982061417738</guid>
<pubDate>Wed, 15 May 2013 18:06:51 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-the-latest-news-142013/&quot; style=&quot;font-size:1.2em&quot;&gt;AstraZeneca plc (ADR) (AZN): The Latest News&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (ADR) (NYSE:GSK), which is also in the acquisition hunt after seeing its operating profit fall 26% in the most recent quarter, has reportedly backed out of the competition after expressing interest early.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Earnings: Eli Lilly &amp;amp; Co (LLY), GlaxoSmithKline plc (GSK), Novartis AG</title>
<link>http://www.valuewalk.com/2013/04/earnings-eli-lilly-co-lly-glaxosmithkline-plc-gsk-novartis-ag/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778130600341</guid>
<pubDate>Wed, 24 Apr 2013 14:52:17 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.valuewalk.com/2013/04/earnings-eli-lilly-co-lly-glaxosmithkline-plc-gsk-novartis-ag/&quot; style=&quot;font-size:1.2em&quot;&gt;Earnings: Eli Lilly &amp;amp; Co (LLY), GlaxoSmithKline plc (GSK), Novartis AG&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;ValueWalk&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (ADR) (NYSE:GSK) saw its first quarter profit decline by 6 percent after the products it divested.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>To GlaxoSmithKline, an Apology</title>
<link>http://www.fool.com/investing/general/2013/04/26/to-glaxosmithkline-an-apology.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778133796200</guid>
<pubDate>Fri, 26 Apr 2013 18:22:25 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.com/investing/general/2013/04/26/to-glaxosmithkline-an-apology.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;To GlaxoSmithKline, an Apology&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;LONDON -- Back in January, I was looking to name (and shame) the five worst stocks on the FTSE 100, when my eyes alighted on GlaxoSmithKline (LSE: GSK ) (NYSE: GSK ) . I fell on it with glee. And why not? Glaxo had been one of my most disappointing ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Three Reasons to Love GlaxoSmithKline plc (GSK)</title>
<link>http://www.insidermonkey.com/blog/three-reasons-to-love-glaxosmithkline-plc-gsk-147546/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982069661287</guid>
<pubDate>Wed, 22 May 2013 16:56:26 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/three-reasons-to-love-glaxosmithkline-plc-gsk-147546/&quot; style=&quot;font-size:1.2em&quot;&gt;Three Reasons to Love GlaxoSmithKline plc (GSK)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;2 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (ADR) (NYSE:GSK) LONDON -- It&amp;#39;s been a long tough slog for GlaxoSmithKline plc (LON:GSK) shares, but things are looking up.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>News Recap: NII Holdings, Companhia Siderurgica Nacional, JDS Uniphase ...</title>
<link>http://www.sbwire.com/press-releases/news-recap-nii-holdings-companhia-siderurgica-nacional-jds-uniphase-corp-glaxosmithkline-plc-245400.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778138288542</guid>
<pubDate>Wed, 01 May 2013 12:48:54 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/news-recap-nii-holdings-companhia-siderurgica-nacional-jds-uniphase-corp-glaxosmithkline-plc-245400.htm&quot; style=&quot;font-size:1.2em&quot;&gt;News Recap: NII Holdings, Companhia Siderurgica Nacional, JDS Uniphase ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 1, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (ADR)(NYSE:GSK) shares declined 1.47% to $51.65. The company reported on April 22, that they have submitted a regulatory petition to the Japanese Ministry of Health, Labour and Welfare, or MHLW, for the investigational once-daily ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GlaxoSmithKline plc (ADR) (NYSE:GSK) Expected To Posts Bearish Results ...</title>
<link>http://galaxystocks.com/33212/nyse-news/glaxosmithkline-plc-adr-nysegsk-expected-to-posts-bearish-results-gsk-wu-dfs-cof-cit/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778129378606</guid>
<pubDate>Tue, 23 Apr 2013 14:57:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://galaxystocks.com/33212/nyse-news/glaxosmithkline-plc-adr-nysegsk-expected-to-posts-bearish-results-gsk-wu-dfs-cof-cit/&quot; style=&quot;font-size:1.2em&quot;&gt;GlaxoSmithKline plc (ADR) (NYSE:GSK) Expected To Posts Bearish Results ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Galaxy Stocks&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;The analysts have turn into surging bearish on GlaxoSmithKline plc (ADR) (NYSE:GSK) in the month leading up to the firm&amp;#39;s Q1 earnings declaration scheduled for Wednesday, April 24, 2013.&lt;/div&gt;
&lt;a href=&quot;http://www.techsonian.com/exelon-corporation-nyseexc-glaxosmithkline-plc-adr-nysegsk-met-pro-corporation-nysempr-ventas-inc-nysevtr/121063/&quot;&gt;Exelon Corporation (NYSE:EXC), GlaxoSmithKline plc (ADR) (NYSE:GSK), Met ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Techsonian (press release)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GlaxoSmithKline PLC ( NYSE : GSK ) Puts Forward Petition to Japanese MHLW ...</title>
<link>http://estocksdaily.com/glaxosmithkline-plc-nysegsk-puts-forward-petition-to-japanese-mhlw-power-one-inc-nasdaqpwer-getting-purchased-by-abb/1242468/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778127938982</guid>
<pubDate>Mon, 22 Apr 2013 14:25:32 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://estocksdaily.com/glaxosmithkline-plc-nysegsk-puts-forward-petition-to-japanese-mhlw-power-one-inc-nasdaqpwer-getting-purchased-by-abb/1242468/&quot; style=&quot;font-size:1.2em&quot;&gt;GlaxoSmithKline PLC ( NYSE : GSK ) Puts Forward Petition to Japanese MHLW ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;eStocksDaily&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 22, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;At the current trading session, GlaxoSmithKline plc (ADR) (NYSE:GSK) shares declined -0.22% to $50.36 while The Stock traded within the range of $50.32 - $50.50.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
